Crossject (ALCJ)

Currency in EUR
1.460
-0.008(-0.55%)
Real-time Data·
ALCJ Scorecard
Full Analysis
Net income is expected to grow this year
ALCJ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.4601.476
52 wk Range
0.7202.750
Key Statistics
Prev. Close
1.468
Open
1.476
Day's Range
1.46-1.476
52 wk Range
0.72-2.75
Volume
7.14K
Average Volume (3m)
235.33K
1-Year Change
-19.78%
Book Value / Share
-0.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALCJ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.300
Upside
+194.52%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Crossject News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Crossject Company Profile

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, a needle-free device for patient-side management disorders self-injectables. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. The company was founded in 2001 and is based in Dijon, France.

Employees
102
Market
France

Compare ALCJ to Peers and Sector

Metrics to compare
ALCJ
Peers
Sector
Relationship
P/E Ratio
−6.0x−1.9x−0.5x
PEG Ratio
0.31−0.030.00
Price/Book
−28.7x1.5x2.6x
Price / LTM Sales
18.7x1.0x3.3x
Upside (Analyst Target)
192.9%48.8%43.5%
Fair Value Upside
Unlock8.8%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.300
(+194.52% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
2.53M / --
EPS Revisions
Last 90 days

ALCJ Income Statement

People Also Watch

68.12
TEPRF
+0.18%
2.4750
ALCPB
-2.17%
20.96
STMPA
-1.62%
6.56
ADOC
-0.15%
15.79
MEDCL
0.00%

FAQ

What Stock Exchange Does Crossject Trade On?

Crossject is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Crossject?

The stock symbol for Crossject is "ALCJ."

What Is the Crossject Market Cap?

As of today, Crossject market cap is 77.11M.

What Is Crossject's Earnings Per Share (TTM)?

The Crossject EPS (TTM) is -0.28.

From a Technical Analysis Perspective, Is ALCJ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Crossject Stock Split?

Crossject has split 2 times.

How Many Employees Does Crossject Have?

Crossject has 102 employees.

What is the current trading status of Crossject (ALCJ)?

As of 07 Aug 2025, Crossject (ALCJ) is trading at a price of 1.46, with a previous close of 1.47. The stock has fluctuated within a day range of 1.46 to 1.48, while its 52-week range spans from 0.72 to 2.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.